Traws Pharma grants 184,492 stock options to five executive officers at $3.01 strike

Traws Pharma, Inc.

CEO Iain Dukes: 64,839 options; CFO Parker, CSO Pauza, CMO Redfield each 32,406; COO Savchuk 22,435.
Exercise price $3.01/share (Oct 10 closing); 10-year term; full vest on first anniversary (Oct 12, 2026).
Granted under Amended and Restated 2021 Incentive Compensation Plan; subject to continued service.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.